Target intelligence / Profile preview

Phosphatidylinositol 3-kinase–Akt–mammalian target of rapamycin–ribosomal protein S6 kinase beta-1 signaling pathway (PI3K-Akt-mTOR-S6K1 signaling pathway)

Target
PI3K-Akt-mTOR-S6K1 signaling pathway
Molecular classification
Other (Intracellular signaling pathway)
01

Overview

The **phosphatidylinositol 3‑kinase–Akt–mammalian target of rapamycin–ribosomal protein S6 kinase beta‑1** (**PI3K‑Akt‑mTOR‑S6K1**) **signaling pathway** is a highly conserved intracellular signal transduction cascade that regulates critical cellular processes including growth, survival, metabolism, proliferation, differentiation, and apoptosis. Activation typically begins at the cell surface via growth factor receptors that stimulate phosphatidylinositol 3‑kinase (**PI3K**), leading to production of phosphoinositide second messengers that recruit **Akt** (**protein kinase B**) to the plasma membrane for activation. Activated Akt phosphorylates numerous substrates involved in promoting survival and growth while inhibiting apoptosis. One major downstream effector is **mammalian/mechanistic target of rapamycin** (**mTOR**), which integrates nutrient sensing with mitogenic signals to regulate translation through phosphorylation/activation of targets like **S6 kinase beta‑1** (**S6K1**, also known as p70S6 kinase). Dysregulation—often via mutation or loss-of-function in negative regulators like PTEN—leads to constitutive activity associated with oncogenesis across many tumor types including breast cancer and acute myeloid leukemia.[1][2][8] The complexity arises because this "target" refers not to one molecule but an entire networked axis comprising multiple druggable nodes. This entry does not correspond to a single molecular entity but rather describes an integrated network/pathway composed primarily of enzymes/kinases; thus it should not be considered a canonical therapeutic "target" per se but rather a collection/set thereof.[2][9]

Other names
PI3K/AKT/mTOR/S6K1 pathwayPI3K-Akt-mTOR pathwayPI3K/AKT/mTOR signaling cascadePhosphoinositide 3-kinase/Akt/mTOR/S6 kinase 1 axis
02

Mechanism of action

Drugs act by inhibiting specific kinases within the pathway to block downstream pro-survival and proliferative signals. For example: - Inhibition of mTOR blocks protein synthesis and cell growth. - Inhibition of PI3K prevents activation of Akt and downstream effectors.

03

Biological functions

Signal transductionCell cycle regulationCell proliferationCell survival (anti-apoptosis)Metabolism regulationDifferentiati on control
04

Disease associations

Cancer (including breast cancer, gastric carcinoma, acute myeloid leukemia)Diabetes mellitus type 2Neurodegenerative diseaseCardiovascular disease
05

Safety considerations

Therapeutic challenges include off-target effects due to broad role in normal cell function; notable concerns are:Hyperglycemia/metabolic disturbances due to interference with insulin signalingImmunosuppression/increased infection risk from inhibition of immune cell proliferationMucositis and cytopenias from effects on rapidly dividing cells
06

Interacting drugs

No drugs directly interact with the entire pathway; instead, drugs target individual components such as PI3K, Akt, or mTOR. Examples include:

5 more in the full profile.

07

Biomarkers

Phosphorylation status of key proteins is used as a biomarker for activation state; examples include:Phospho-AKT Ser473Phospho-S6 ribosomal protein

Beyond the preview

Go deeper on Phosphatidylinositol 3-kinase–Akt–mammalian target of rapamycin–ribosomal protein S6 kinase beta-1 signaling pathway (PI3K-Akt-mTOR-S6K1 signaling pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol 3-kinase–Akt–mammalian target of rapamycin–ribosomal protein S6 kinase beta-1 signaling pathway (PI3K-Akt-mTOR-S6K1 signaling pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call